Jon Charles Tilburt

Jon Charles Tilburt

Auto-generated profile, based on publicly available information

Jon Charles Tilburt

Biomedical Ethics Research Program, Mayo Clinic

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2013 in BMC Medical Ethics
Verified
Journal Article
Open access
PDF file
ANAdam Nishimura
Adam Nishimura
JCJantey Carey
Jantey Carey
PEPatricia J Erwin
Patricia J Erwin
JTJon C Tilburt
Jon C Tilburt
MMM Hassan Murad
M Hassan Murad
JMJennifer B. McCormick
Jennifer B. McCormick
Background: Obtaining informed consent is a cornerstone of biomedical research, yet participants comprehension of presented information is often low. The most effective interventions to improve understanding rates have not been identified. Purpose: To systematically analyze the random controlled trials testing interventions to research informed consent process. The primary outcome of interest was quantitative rates of participant understanding; secondary outcomes were rates of information retention, satisfaction, and accrual. Interventional categories included multimedia, enhanced consent documents, extended discussions, test/feedback quizzes, and miscellaneous methods. Methods: The search spanned from database inception through September 2010. It was run on Ovid MEDLINE, Ovid EMBASE, Ovid CINAHL, Ovid PsycInfo and Cochrane CENTRAL, ISI Web of Science and Scopus. Five reviewers working independently and in duplicate screened full abstract text to determine eligibility. We included only RCTs. 39 out of 1523 articles fulfilled review criteria (2.6%), with a total of 54 interventions. A data extraction form was created in Distiller, an online reference management system, through an iterative process. One author collected data on study design, population, demographics, intervention, and analytical technique. Results: Meta-analysis was possible on 22 interventions: multimedia, enhanced form, and extended discussion categories; all 54 interventions were assessed by review. Meta-analysis of multimedia approaches was associated with a non-significant increase in understanding scores (SMD 0.30, 95% CI, -0.23 to 0.84); enhanced consent form, with significant increase (SMD 1.73, 95% CI, 0.99 to 2.47); and extended discussion, with significant increase (SMD 0.53, 95% CI, 0.21 to 0.84). By review, 31% of multimedia interventions showed significant improvement in understanding; 41% for enhanced consent form; 50% for extended discussion; 33% for test/feedback; and 29% for miscellaneous.Multiple sources of variation existed between included studies: control processes, the presence of a human proctor, real vs. simulated protocol, and assessment formats. Conclusions: Enhanced consent forms and extended discussions were most effective in improving participant understanding. Interventions of all categories had no negative impact on participant satisfaction or study accrual. Identification of best practices for studies of informed consent interventions would aid future systematic comparisons.

23 October 2008 in BMJ
Verified
Journal Article
Open access
PDF file
JTJon C Tilburt
Jon C Tilburt
EEEzekiel J Emanuel
Ezekiel J Emanuel
TKTed J Kaptchuk
Ted J Kaptchuk
FCFarr A Curlin
Farr A Curlin
FMFranklin G Miller
Franklin G Miller
Objective To describe the attitudes and behaviours regarding placebo treatments, defined as a treatment whose benefits derive from positive patient expectations and not from the physiological mechanism of the treatment itself. Design Cross sectional mailed survey. Setting Physicians’ clinical practices. Participants 1200 practising internists and rheumatologists in the United States. Main outcome measures Investigators measured physicians’ self reported behaviours and attitudes concerning the use of placebo treatments, including measures of whether they would use or had recommended a “placebo treatment,” their ethical judgments about the practice, what they recommended as placebo treatments, and how they typically communicate with patients about the practice. Results 679 physicians (57%) responded to the survey. About half of the surveyed internists and rheumatologists reported prescribing placebo treatments on a regular basis (46-58%, depending on how the question was phrased). Most physicians (399, 62%) believed the practice to be ethically permissible. Few reported using saline (18, 3%) or sugar pills (12, 2%) as placebo treatments, while large proportions reported using over the counter analgesics (267, 41%) and vitamins (243, 38%) as placebo treatments within the past year. A small but notable proportion of physicians reported using antibiotics (86, 13%) and sedatives (86, 13%) as placebo treatments during the same period. Furthermore, physicians who use placebo treatments most commonly describe them to patients as a potentially beneficial medicine or treatment not typically used for their condition (241, 68%); only rarely do they explicitly describe them as placebos (18, 5%). Conclusions Prescribing placebo treatments seems to be common and is viewed as ethically permissible among the surveyed US internists and rheumatologists. Vitamins and over the counter analgesics are the most commonly used treatments. Physicians might not be fully transparent with their patients about the use of placebos and might have mixed motivations for recommending such treatments.

24 July 2013 in JAMA
Verified
Journal Article
Open access
PDF file
JTJon C. Tilburt
Jon C. Tilburt
MWMatthew K. Wynia
Matthew K. Wynia
RSRobert D. Sheeler
Robert D. Sheeler
BTBjorg Thorsteinsdottir
Bjorg Thorsteinsdottir
KJKatherine M. James
Katherine M. James
SGSusan Dorr Goold
Susan Dorr Goold
The increasing cost of US health care strains the economy. Because physicians’ decisions play a key role in overall health care spending and quality, several recent initiatives have called on physicians to reduce waste and exercise wise stewardship of resources.1-4 Given their roles, physicians’ perspectives on policies and strategies related to cost containment and their perceived responsibilities as stewards of health care resources in general are increasingly germane to recent pending and proposed policy reforms.5 We surveyed US physicians about their views on several potential proposed policies and strategies to contain health care spending, assessed physicians’ perceived roles and responsibilities in addressing health care costs, and ascertained physician characteristics associated with those views.

19 May 2011 in Hereditary Cancer in Clinical Practice
Verified
Journal Article
Open access
PDF file
JTJon C Tilburt
Jon C Tilburt
KJKatherine M James
Katherine M James
PSPamela S Sinicrope
Pamela S Sinicrope
DEDavid T Eton
David T Eton
BCBrian A Costello
Brian A Costello
MMMohammad H Murad
Mohammad H Murad
Patients at higher than average risk of heritable cancer may process risk information differently than the general population. However, little is known about clinical, demographic, or psychosocial predictors that may impact risk perception in these groups. The objective of this study was to characterize factors associated with perceived risk of developing cancer in groups at high risk for cancer based on genetics or family history.

6 March 2014 in Systematic Reviews
Verified
Journal Article
Open access
PDF file
ALAaron Leppin
Aaron Leppin
MGMichael R Gionfriddo
Michael R Gionfriddo
ASAmit Sood
Amit Sood
VMVictor M Montori
Victor M Montori
PEPatricia J Erwin
Patricia J Erwin
JTJon C Tilburt
Jon C Tilburt
Resilience has been defined as the ability of individuals to manage and adapt to stress and life challenges. Training programs that develop and/or enhance resilience may have efficacy in improving health, well-being, and quality of life. Because patients with chronic conditions must reliably self-manage their health, strategies to bolster resilience in this population may be of particular value. The objectives of this systematic review are to synthesize the evidence of resilience training program efficacy in improving outcomes related to quality of life, self-efficacy and activation, and resilience and coping ability in: 1) diverse adult populations; and 2) patients with chronic conditions.

1 September 2008 in Vaccine
Verified
Journal Article
Closed access
JTJon C. Tilburt
Jon C. Tilburt
PMPaul S. Mueller
Paul S. Mueller
AOAbigale L. Ottenberg
Abigale L. Ottenberg
GPGregory A. Poland
Gregory A. Poland
BKBarbara A. Koenig
Barbara A. Koenig